Recent Advances in Solid Tumor CAR-T Cell Therapy: Driving Tumor Cells From Hero to Zero?

Chimeric antigen receptor T-cells (CAR-Ts) are known as revolutionary living drugs that have turned the tables of conventional cancer treatments in certain hematologic malignancies such as B-cell acute lymphoblastic leukemia (B-ALL) and diffuse large B-cell lymphoma (DLBCL) by achieving US Food and...

Descripción completa

Detalles Bibliográficos
Autores principales: Safarzadeh Kozani, Pouya, Safarzadeh Kozani, Pooria, Ahmadi Najafabadi, Milad, Yousefi, Fatemeh, Mirarefin, Seyed Mohamad Javad, Rahbarizadeh, Fatemeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130586/
https://www.ncbi.nlm.nih.gov/pubmed/35634281
http://dx.doi.org/10.3389/fimmu.2022.795164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130586/
https://www.ncbi.nlm.nih.gov/pubmed/35634281
http://dx.doi.org/10.3389/fimmu.2022.795164

Ejemplares similares